Why AngioDynamics Stock Popped, Then Dropped Today
Tuesday started off well for AngioDynamics (NASDAQ: ANGO), maker of such medical devices as the NanoKnife tool for "electrocuting" cancer, as well as multiple devices for treating peripheral vascular disease. In the morning, AngioDynamics reported stronger-than-expected Q4 2025 sales and earnings, with sales of $80.2 million and an adjusted loss of $0.03 per share (instead of the $0.12-per-share forecast).
By the end of the day, however, the rally fell completely apart. AngioDynamics ended up closing down almost 10% for the day. So what went wrong?
Image source: Getty Images.
Source Fool.com
Angiodynamics Inc. Stock
€11.20
-0.890%
The community is currently still undecided about Angiodynamics Inc. with 1 Buy predictions and 0 Sell predictions.
As a result the target price of 13 € shows a slightly positive potential of 16.07% compared to the current price of 11.2 € for Angiodynamics Inc..
